NEWSGi-Hoon Nam, CEO of SHIFTBIO INC., Featured Speaker at ISCT 2024 in Vancouver

12 Jun 2024

SHIFTBIO INC. participated in the prestigious International Society for Cell & Gene Therapy (ISCT) 2024 conference in Vancouver, Canada.

Gi-Hoon Nam, the CEO of SHIFTBIO INC., attended as an invited speaker and delivered both a session and a poster presentation, significantly expanding our network with distinguished global researchers. Through these presentations, SHIFTBIO introduced our proprietary NSM platform technology and our first pipeline, SBI-102. Additionally, we've attended various sessions to gain insights into global CGT market trends and engaged in productive meetings to discuss potential collaborative research opportunities.

SHIFTBIO remains committed to unwavering progress and innovation. Please stay tuned for our upcoming developments and achievements!